Cision PR Newswire

/DISREGARD RELEASE: Jiangsu Vcare/

We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire.

MemeStrategy (2440.HK) Partners with Leading Crypto Platform Helio, Providing Technical Advisory Support for AI-powered Meme Money Markets, Transforming Viral Memes into New Digital Era

HONG KONG, Aug. 1, 2025 /PRNewswire/ -- MemeStrategy, Inc. ("MemeStrategy" or "the Company," Stock Code: 2440.HK), Asia's first publicly listed digital asset company, and...

RWA Group Secures Strategic Investment from Meta Strategy to Accelerate RWA Ecosystem Growth

HONG KONG, Aug. 1, 2025 /PRNewswire/ -- RWA Group Limited, a leading real-world asset (RWA) tokenization and infrastructure service provider based in Hong Kong,...

DermRays Elevates Upgraded Revive & Debuts World’s First Men’s At-Home Hair Removal Diode Laser Device, V10S

PLEASANTON, Calif., Aug. 1, 2025 /PRNewswire/ -- DermRays, a leader in professional-grade at-home hair removal solutions, today announced a major upgrade to its Revive...

New Force in Vaccine National Team: NHRI Spin-off ‘TaiU’ Completes US$2M Seed Round Led by MVL Seed Fund

TAIPEI, Aug. 1, 2025 /PRNewswire/ -- Taiwan Universe BioMedicine (TaiU), a startup spun off from the National Health Research Institutes (NHRI), today announced the completion...